Pharmacoeconomic evaluation of long-term treatment with risperidone for patients with chronic schizophrenia

British Journal of Medical Economics

Volumn 10, Issue 1, 1996, Pages 59-67

  Guest, J F ^a   Hart, W M ^a   Cookson, R F ^a   Lindstrom, E ^a  

^a Catalyst Healthcare Communications   (United Kingdom)

Author keywords

Antipsychotic treatment; Costs; Pharmacoeconomics; Schizophrenia

Indexed keywords

CLOZAPINE; PERPHENAZINE; RISPERIDONE; THIORIDAZINE; ZUCLOPENTHIXOL;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST CONTROL; DRUG COST; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LONG TERM CARE; PHARMACOECONOMICS; RATING SCALE; RESIDENTIAL CARE; SCHIZOPHRENIA; UNITED KINGDOM;

EID: 0029998706     PISSN: 09621423     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)